Phosphoric Acid

Phosphoric Acid

SCHEMBL1824747

C=CC=CCC.O=P(O)(O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.43
LPAR2 Q9HBW0 2/20 0.35
LPAR3 Q9UBY5 2/20 0.35
LPAR1 Q92633 1/20 0.35
LAP3 P28838 1/20 0.33
GABRR1 P24046 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL1825285 1.00 TRPA1 (0.43) TRPA1LPAR2LPAR3LPAR1LAP3
SCHEMBL1760692 0.86
SCHEMBL22112 0.86
SCHEMBL22111 0.86
Bicarbonate SCHEMBL980471 0.84 TRPA1 (0.43) TRPA1ALDH1A1TSHR
Alcohol SCHEMBL29101440 0.83
SCHEMBL23650044 0.83
SCHEMBL11246643 0.83
Butadiene SCHEMBL4181280 0.83 TRPA1 (0.45) TRPA1
Methane SCHEMBL19112338 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0968223-B1 BIOCONJUGATION OF MACROMOLECULES SIGMA ALDRICH CO LLC (US) 2016-12-21 EP disclosed
EP-2256133-B1 Bioconjugation of macromolecules SIGMA ALDRICH CO LLC (US) 2016-12-14 EP disclosed
EP-2319854-B1 Bioconjugation Of Macromolecules SIGMA ALDRICH CO LLC (US) 2016-11-30 EP disclosed
EP-2319855-B1 Bioconjugation of Macromolecules SIGMA ALDRICH CO LLC (US) 2016-04-06 EP disclosed
EP-2319855-A1 Bioconjugation of Macromolecules Sigma-Aldrich Co. (US) 2011-05-11 EP disclosed
EP-2319854-A1 Bioconjugation Of Macromolecules Sigma-Aldrich Co. (US) 2011-05-11 EP disclosed
EP-2256133-A1 Bioconjugation of macromolecules Sigma-Aldrich Co. (US) 2010-12-01 EP disclosed
US-7427678-B2 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method SIGMA-ALDRICH CO. (US) 2008-09-23 US disclosed
US-6737236-B1 DERIVATIZING OLIGONUCLEOTIDES AND PROTEINS USING CYCLOADDITION REACTIONS INCLUDING DIELS-ALDER REACTION OR 1,3-DIPOLAR CYCLOADDITION REACTIONS PROLIGO, LLC 2004-05-18 US disclosed
US-20030215801-A1 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method SIGMA-ALDRICH CO., LLC 2003-11-20 US disclosed
EP-1287404-A4 METHOD FOR IMMOBILIZING OLIGONUCLEOTIDES EMPLOYING THE CYCLOADDITION BIOCONJUGATION METHOD PROLIGO LLC (US) 2003-10-15 EP disclosed
EP-1287404-A1 METHOD FOR IMMOBILIZING OLIGONUCLEOTIDES EMPLOYING THE CYCLOADDITION BIOCONJUGATION METHOD Proligo LLC (US) 2003-03-05 EP disclosed
WO-2001084234-A1 METHOD FOR IMMOBILIZING OLIGONUCLEOTIDES EMPLOYING THE CYCLOADDITION BIOCONJUGATION METHOD PROLIGO LLC (US) 2001-11-08 WO disclosed
EP-0968223-A1 BIOCONJUGATION OF MACROMOLECULES Proligo L.L.C. (US) 2000-01-05 EP disclosed
WO-1998030575-A1 BIOCONJUGATION OF MACROMOLECULES PROLIGO LLC (US) 1998-07-16 WO disclosed